Jubilant Life Sciences Ltd. has signed an agreement to buy the radiopharmacy business of U.S. based Triad Isotopes Inc. The drug maker will carry out the agreement through its wholly-owned subsidiary, Jubilant Pharma Ltd.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
